A Study to Investigate RO7200220 as Monotherapy and in Combination With Ranibizumab in Participants With Diabetic and Uveitic Macular Edema

NCT06771271 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

85

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Macular Edema
Uveitic Macular Edema

Interventions

DRUG: RO7200220
DRUG: Ranibizumab

Sponsor

Hoffmann-La Roche